(Q30455525)

21 June 2017

title

The future of molecular diagnostics for drug-resistant tuberculosis (English)

1 reference

21 June 2017

0 references

2

Eric R Houpt

1 reference

21 June 2017

1

Scott K Heysell

1 reference

21 June 2017

publication date

1 May 2012

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

21 June 2017

published in

1 reference

21 June 2017

volume

12

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

395-405

1 reference

HIV infection and multidrug-resistant tuberculosis: the perfect storm

21 June 2017

cites work

1 reference

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

21 January 2018

1 reference

Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.

21 January 2018

1 reference

Totally drug-resistant tuberculosis in India.

21 January 2018

1 reference

From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis

21 January 2018

1 reference

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study

21 January 2018

1 reference

Multidrug-resistant and extensively drug-resistant tuberculosis: consequences for the global HIV community

21 January 2018

1 reference

Cost-effectiveness of treating multidrug-resistant tuberculosis

21 January 2018

1 reference

Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)--report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibili

21 January 2018

1 reference

Drug-susceptibility testing in tuberculosis: methods and reliability of results

21 January 2018

1 reference

Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance loci

21 January 2018

1 reference

Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis

21 January 2018

1 reference

Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study

21 January 2018

1 reference

Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials

21 January 2018

1 reference

Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis

21 January 2018

1 reference

Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation

21 January 2018

1 reference

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

21 January 2018

1 reference

Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis

21 January 2018

1 reference

Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol

21 January 2018

1 reference

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

21 January 2018

1 reference

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods

21 January 2018

1 reference

The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol.

21 January 2018

1 reference

Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis

21 January 2018

1 reference

Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States

21 January 2018

1 reference

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

21 January 2018

1 reference

Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs

21 January 2018

1 reference

Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations

21 January 2018

1 reference

Fluoroquinolones, tuberculosis, and resistance

21 January 2018

1 reference

Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.

21 January 2018

1 reference

Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates

21 January 2018

1 reference

First linezolid-resistant clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis

21 January 2018

1 reference

Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis

21 January 2018

1 reference

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

21 January 2018

1 reference

Use of the INNO LiPA Rif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility.

21 January 2018

1 reference

Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis

21 January 2018

1 reference

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

21 January 2018

1 reference

Rapid molecular detection of tuberculosis and rifampin resistance

21 January 2018

1 reference

Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study

21 January 2018

1 reference

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

21 January 2018

1 reference

A balancing act: efflux/influx in mycobacterial drug resistance

21 January 2018

1 reference

Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colourimetric methods

21 January 2018

1 reference

Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method

21 January 2018

1 reference

Multicenter evaluation of the nitrate reductase assay for drug resistance detection of Mycobacterium tuberculosis.

21 January 2018

1 reference

Microscopic-observation drug-susceptibility assay for the diagnosis of TB

21 January 2018

1 reference

Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method

21 January 2018

1 reference

Improved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility technique

21 January 2018

1 reference

Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay

21 January 2018

1 reference

Development of a bacteriophage phage replication assay for diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

Bacteriophage- based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta- analysis

21 January 2018

1 reference

Rapid, standardized method for determination of Mycobacterium tuberculosis drug susceptibility by use of mycolic acid analysis

21 January 2018

1 reference

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis

21 January 2018

1 reference

Comprehensive treatment of extensively drug-resistant tuberculosis.

21 January 2018

1 reference

High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene

21 January 2018

1 reference

Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.

21 January 2018

1 reference

Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis

21 January 2018

1 reference

Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa

21 January 2018

1 reference

Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.12.25

1 reference

21 June 2017

1 reference